Ziopharm Oncology buy exploration
Start price
22.04.16
/
50%
€7.12
Target price
19.07.16
€10.10
Performance (%)
-43.45%
End price
19.07.16
€4.03
Summary
This prediction ended on 19.07.16 with a price of €4.03. Massive losses of -43.45% were the result for the BUY prediction by exploration. exploration has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ziopharm Oncology | - | - | - | - |
| iShares Core DAX® | -3,51 % | -8,75 % | -1,00 % | 48,50 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % | 14,22 % | 78,81 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % | 24,87 % | 51,56 % |
| iShares S&P 500 | -2,60 % | -2,23 % | 9,20 % | 60,51 % |
Comments by exploration for this prediction
In the thread Ziopharm Oncology diskutieren
Ziopharm: Biotechwerte werden wieder interessant
langfristig werden auch Biotechwerte wieder interessant.
(Stop Loss Kurs erreicht)


